02-08-2017, 07:05 PM
(02-08-2017, 02:21 PM)EricL Wrote: Yeah, I've learned pretty quickly that biotech is the wild, wild west of investing in the healthcare sector. I'll continue holding what I've got, but going forward I think I'll focus more on the JNJ/BDX/ABT/SYK/BAX types rather than the drug companies.
I'm learning this too. I will hold GILD because I still believe long term (5+ years) they will be a solid company. However, moving forward, my only biotech investment will be a biotech ETF like IBB. It is simply too difficult for DIY investors to analyze a company's drug pipeline, predict FDA approvals, predict revenue from those approvals, deal with drugs going off patent, deal with competition from other companies, etc.